These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2703975)

  • 1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
    Garrigou-Gadenne D; Burke JT; Durand A; Depoortere H; Thénot JP; Morselli PL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1283-8. PubMed ID: 2703975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
    Scatton B; Claustre Y; Dennis T; Nishikawa T
    J Pharmacol Exp Ther; 1986 May; 237(2):659-65. PubMed ID: 2871179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.
    Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-chronic administration of zolpidem affects modifications to rat sleep architecture.
    Renger JJ; Dunn SL; Motzel SL; Johnson C; Koblan KS
    Brain Res; 2004 Jun; 1010(1-2):45-54. PubMed ID: 15126116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
    Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
    Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects.
    de Haas SL; Schoemaker RC; van Gerven JM; Hoever P; Cohen AF; Dingemanse J
    J Psychopharmacol; 2010 Nov; 24(11):1619-29. PubMed ID: 19648220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the hypnotic drug zolpidem on cell proliferation and survival in the dentate gyrus of young and old rats.
    Takase LF; Fornal CA; Jacobs BL
    Brain Res; 2009 Mar; 1259():26-31. PubMed ID: 19138676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.
    Bogan RK
    Postgrad Med; 2008 Sep; 120(3):161-71. PubMed ID: 18824834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret.
    Hsu N; Jha SK; Coleman T; Frank MG
    Behav Brain Res; 2009 Jul; 201(1):233-6. PubMed ID: 19428639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of tiropramide and metabolites after single intravenous or peroral administration of 14C-tiropramide to the rat.
    Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
    Arzneimittelforschung; 1989 May; 39(5):579-86. PubMed ID: 2757674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.